Trial Profile
A retrospective study analysing treatment outcomes with everolimus, tacrolimus and cyclosporine A in the prevalence of arterial hypertension among patients after successful liver transplantation and the pathogenesis of hypertension in liver transplant patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Everolimus (Primary) ; Tacrolimus (Primary)
- Indications Hypertension; Liver transplant rejection
- Focus Adverse reactions
- 14 Nov 2016 New trial record